Lunit

News

An AI could help to detect aggressive interval breast cancers that are diagnosed in between routine screening appointments, say US researchers.

News

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.